Cite
APA Citation
Conte, B., Montemurro, F., Levaggi, A., Blondeaux, E., Molinelli, C., Cardinali, B., Poggio, F., Buzzatti, G., Bighin, C., Lambertini, M., & Del Mastro, L. (2023). anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial. Tumori, 109(1), 71–78. http://access.bl.uk/ark:/81055/vdc_100173394013.0x000015